Replies to post #84613 on Cytodyn Inc (CYDY)

[Venture_Cap]

Even if Leronlimab aces the trials the FDA won’t make a public proclamation like they did with remdesivir as a SOC.

Too much money to lose. Leronlimab will simply be put to use in hospitals with not much fanfare. Then after a few months of manufacturing and inventory it’ll make it mainstream. I’d say September the news will pick up on it as a household name.